• The research at the Institute of Radiation Biology (ISB) focuses on the health challenges posed by the chronic diseases that develop in long-term survivors of cancer radiotherapy. Our goal is to minimise the pathophysiology, in particular in tissues at the periphery of the radiation field receiving low radiation doses. The research groups examine the physiological effects of low doses of radiation in the brain, heart and lung tissue, in stem cells and in endothelial cells. We are developing pharmacological strategies to lower radiation doses and to ameliorate damage, and we investigate the influence of genetic and epigenetic regulation in determining the response of individual patients. The ISB is a part of the Department of Radiation Sciences (DRS).